跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,572 条关于
“antibody oligonucleotide conjugate”
全部
14,572
临床试验
5,621
药物
2,845
机构
63
资讯
6,043
去年
Avidity Biosciences Secures $345M Following Promising Duchenne Muscular Dystrophy Trial Results
10个月前
Novartis Announces $12 Billion Acquisition of Avidity Biosciences to Advance RNA-Based Neuromuscular Therapeutics
去年
FDA Grants Breakthrough Therapy Designation to Avidity's Del-zota for Duchenne Muscular Dystrophy
2年前
Avidity's Delpacibart Etedesiran Granted FDA Breakthrough Therapy Designation for Myotonic Dystrophy Type 1
10天前
Novartis' Del-desiran Misses Primary Endpoint in Phase 3 HARBOR, Rattling DMPK-Targeting Field
3个月前
Novartis' Del-Brax Hits Primary Biomarker Endpoint in Phase I/II FSHD Trial, Paving Way for First Disease-Modifying Therapy
去年
FDA Lifts Clinical Hold on Avidity's Delpacibart Etedesiran (AOC 1001) for Myotonic Dystrophy Type 1
去年
Japan Grants First Orphan Drug Designation for Myotonic Dystrophy Type 1 to Avidity's Del-desiran
12个月前
Avidity Biosciences Advances RNA Therapeutics with Clinical Trials for Rare Diseases
9天前
Alteogen licenses ALT-B4 to Novartis in deal worth up to $3.2 billion
第 1 页，共 605 页
上一页
下一页
